Curium Expands European Supply of Iodine-131 Diagnostic Capsules with New Partnership Agreement with Izotop

PARIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has expanded its existing partnership with Institute of Isotopes Co. Ltd. (Izotop) to make Iodine-131 diagnostic capsules available to patients in the Nordic Region and in other European countries later in 2025, with regulatory approval processes in progress. Today’s announcement follows the expansion in 2024 of Curium’s I-131 production capacity in Petten, NL including adding an additional manufactu ...